Authors: Abrams, LS Skee, DM Natarajan, J Wong, FA Leese, PT Creasy, GW Shangold, MM

Citation: Ls. Abrams et al., Pharmacokinetics of norelgestromin and ethinyl estradiol delivered by a contraceptive patch (Ortho Evra (TM)/Evra (TM)) under conditions of heat, humidity, and exercise, J CLIN PHAR, 41(12), 2001, pp. 1301-1309

Authors: Chow, AT Fowler, C Williams, RR Morgan, N Kaminski, S Natarajan, J

Citation: At. Chow et al., Safety and pharmacokinetics of multiple 750-milligram doses of intravenouslevofloxacin in healthy volunteers, ANTIM AG CH, 45(7), 2001, pp. 2122-2125

Authors: Cheung, WK Natarajan, J Sanders, M Vercammen, E

Citation: Wk. Cheung et al., Comparative pharmacokinetics, safety, and tolerability after subcutaneous administration of recombinant human erythropoietin formulated with different stabilizers, BIOPHARM DR, 21(6), 2000, pp. 211-219

Authors: Gisclon, LG Curtin, CR Larson, KL Natarajan, J Wong, FA Morrison, DN Bourg, D

Citation: Lg. Gisclon et al., Lack of effect of a high-fat meal on the bioavailability of 17 beta-estradiol/norgestimate in healthy postmenopausal women, J CLIN PHAR, 40(7), 2000, pp. 762-769

Authors: Gisclon, LG Bowen, AJ O'Reilly, TE Lakewold, D Curtin, CR Larson, KL Palmer, SA Natarajan, J Wong, FA

Citation: Lg. Gisclon et al., Bioequivalence of a newly developed 17 beta-estradiol tablet versus an identical reference formulation, ARZNEI-FOR, 50(10), 2000, pp. 910-914

Authors: Piscitelli, SC Spooner, K Baird, B Chow, AT Fowler, CL Williams, RR Natarajan, J Masur, H Walker, RE

Citation: Sc. Piscitelli et al., Pharmacokinetics and safety of high-dose and extended-interval regimens oflevofloxacin in human immunodeficiency virus-infected patients, ANTIM AG CH, 43(9), 1999, pp. 2323-2327